ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2025
Reply to: Disparities in Allograft Access in the Era of Post-Transplant Cyclophosphamide-Based Mismatched Unrelated Donor Transplantation.
Abstract read
In one paragraph
Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Brian C ShafferBrian C. Shaffer, MD, MS, Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Mahasweta Gooptu, MD, Medical Oncology, Dana-Farber Cancer Institute, Brookline, MA; Todd DeFor, MS, Stephen R. Spellman, MBS, and Heather E. Stefanski, MD, PhD, CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN; Bronwen E. Shaw, MD, PhD, CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI; Jeffery J. Auletta, MD and Steven M. Devine, MD, CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN; Antonio M. Jimenez, MD, MSc, Sylvester Comprehensive Cancer Center, Miller School of Medicine, Miami, FL; and Monzr M. Al Malki, MD, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA.ORCID 0000-0003-3433-9179
Mahasweta GooptuBrian C. Shaffer, MD, MS, Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Mahasweta Gooptu, MD, Medical Oncology, Dana-Farber Cancer Institute, Brookline, MA; Todd DeFor, MS, Stephen R. Spellman, MBS, and Heather E. Stefanski, MD, PhD, CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN; Bronwen E. Shaw, MD, PhD, CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI; Jeffery J. Auletta, MD and Steven M. Devine, MD, CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN; Antonio M. Jimenez, MD, MSc, Sylvester Comprehensive Cancer Center, Miller School of Medicine, Miami, FL; and Monzr M. Al Malki, MD, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA.
Todd DeForBrian C. Shaffer, MD, MS, Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Mahasweta Gooptu, MD, Medical Oncology, Dana-Farber Cancer Institute, Brookline, MA; Todd DeFor, MS, Stephen R. Spellman, MBS, and Heather E. Stefanski, MD, PhD, CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN; Bronwen E. Shaw, MD, PhD, CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI; Jeffery J. Auletta, MD and Steven M. Devine, MD, CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN; Antonio M. Jimenez, MD, MSc, Sylvester Comprehensive Cancer Center, Miller School of Medicine, Miami, FL; and Monzr M. Al Malki, MD, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA.
Stephen R SpellmanBrian C. Shaffer, MD, MS, Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Mahasweta Gooptu, MD, Medical Oncology, Dana-Farber Cancer Institute, Brookline, MA; Todd DeFor, MS, Stephen R. Spellman, MBS, and Heather E. Stefanski, MD, PhD, CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN; Bronwen E. Shaw, MD, PhD, CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI; Jeffery J. Auletta, MD and Steven M. Devine, MD, CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN; Antonio M. Jimenez, MD, MSc, Sylvester Comprehensive Cancer Center, Miller School of Medicine, Miami, FL; and Monzr M. Al Malki, MD, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA.
Heather E StefanskiBrian C. Shaffer, MD, MS, Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Mahasweta Gooptu, MD, Medical Oncology, Dana-Farber Cancer Institute, Brookline, MA; Todd DeFor, MS, Stephen R. Spellman, MBS, and Heather E. Stefanski, MD, PhD, CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN; Bronwen E. Shaw, MD, PhD, CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI; Jeffery J. Auletta, MD and Steven M. Devine, MD, CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN; Antonio M. Jimenez, MD, MSc, Sylvester Comprehensive Cancer Center, Miller School of Medicine, Miami, FL; and Monzr M. Al Malki, MD, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA.
Bronwen E ShawBrian C. Shaffer, MD, MS, Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Mahasweta Gooptu, MD, Medical Oncology, Dana-Farber Cancer Institute, Brookline, MA; Todd DeFor, MS, Stephen R. Spellman, MBS, and Heather E. Stefanski, MD, PhD, CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN; Bronwen E. Shaw, MD, PhD, CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI; Jeffery J. Auletta, MD and Steven M. Devine, MD, CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN; Antonio M. Jimenez, MD, MSc, Sylvester Comprehensive Cancer Center, Miller School of Medicine, Miami, FL; and Monzr M. Al Malki, MD, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA.ORCID 0000-0003-3317-1896
Jeffery J AulettaBrian C. Shaffer, MD, MS, Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Mahasweta Gooptu, MD, Medical Oncology, Dana-Farber Cancer Institute, Brookline, MA; Todd DeFor, MS, Stephen R. Spellman, MBS, and Heather E. Stefanski, MD, PhD, CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN; Bronwen E. Shaw, MD, PhD, CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI; Jeffery J. Auletta, MD and Steven M. Devine, MD, CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN; Antonio M. Jimenez, MD, MSc, Sylvester Comprehensive Cancer Center, Miller School of Medicine, Miami, FL; and Monzr M. Al Malki, MD, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA.ORCID 0000-0002-1515-2141
Steven M DevineBrian C. Shaffer, MD, MS, Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Mahasweta Gooptu, MD, Medical Oncology, Dana-Farber Cancer Institute, Brookline, MA; Todd DeFor, MS, Stephen R. Spellman, MBS, and Heather E. Stefanski, MD, PhD, CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN; Bronwen E. Shaw, MD, PhD, CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI; Jeffery J. Auletta, MD and Steven M. Devine, MD, CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN; Antonio M. Jimenez, MD, MSc, Sylvester Comprehensive Cancer Center, Miller School of Medicine, Miami, FL; and Monzr M. Al Malki, MD, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA.ORCID 0000-0001-7731-759X
Antonio M JimenezBrian C. Shaffer, MD, MS, Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Mahasweta Gooptu, MD, Medical Oncology, Dana-Farber Cancer Institute, Brookline, MA; Todd DeFor, MS, Stephen R. Spellman, MBS, and Heather E. Stefanski, MD, PhD, CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN; Bronwen E. Shaw, MD, PhD, CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI; Jeffery J. Auletta, MD and Steven M. Devine, MD, CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN; Antonio M. Jimenez, MD, MSc, Sylvester Comprehensive Cancer Center, Miller School of Medicine, Miami, FL; and Monzr M. Al Malki, MD, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA.ORCID 0000-0003-2817-6836
Monzr M Al MalkiBrian C. Shaffer, MD, MS, Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Mahasweta Gooptu, MD, Medical Oncology, Dana-Farber Cancer Institute, Brookline, MA; Todd DeFor, MS, Stephen R. Spellman, MBS, and Heather E. Stefanski, MD, PhD, CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN; Bronwen E. Shaw, MD, PhD, CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI; Jeffery J. Auletta, MD and Steven M. Devine, MD, CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN; Antonio M. Jimenez, MD, MSc, Sylvester Comprehensive Cancer Center, Miller School of Medicine, Miami, FL; and Monzr M. Al Malki, MD, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA.ORCID 0000-0001-8226-471X
Funding
Data Resource for Analyzing Blood &Marrow TransplantsU24CA076518 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI Amy M Moskop, Bronwen Shaw · 1998 to 2026
$105.2MClinical and mechanistic studies defining optimal preparative approaches to infants with IL2RG/JAK3/RAG1/RAG2 SCID: a randomized trial of busulfan dosageU01AI184132 · NIAID · NATIONAL MARROW DONOR PROGRAM · PI JEFFERY J AULETTA, Michael A Pulsipher · 2024 to 2026
$3.2MBMT Core - Pediatric Transplantation and Cellular Therapy Consortium (PTCTC): Providing Clinical Trial Access For Children With Life Threatening DiseasesUG1HL174426 · NHLBI · NATIONAL MARROW DONOR PROGRAM · PI Leslie S Kean, Heather E Stefanski · 2024 to 2026
$513kNCI NIH HHS U24 CA076518NHLBI NIH HHS UG1 HL174426NIAID NIH HHS U01 AI184132
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.